The Use of Inhaled Nitric Oxide After Pediatric Cardiac Surgery.

Physiological response following inhaled nitric oxide administration during one-lung ventilation in minimally invasive cardiac surgery: an exploratory prospective cohort study.

Systemic and pulmonary hemodynamic effects of inhaled high-concentration nitric oxide in patients with coronary artery disease

Inhalation of nitric oxide at a concentration of 200 ppm for 30 minutes does not affect systemic hemodynamic parameters, demonstrating its safety profile in CAD patients after CABG.

Inhaled nitric oxide: Expanding indications beyond traditional boundaries

Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator that improves ventilation–perfusion matching with minimal effect on systemic blood pressure. Although the FDA approval is restricted to neonatal hypoxic respiratory failure associated with pulmonary hypertension, many clinicians now use iNO in adults with...

A Retrospective Analysis of Inhaled Nitric Oxide and Outcomes in Mechanically Ventilated Patients with COVID-19 ARDS

Background: Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator used as rescue therapy in acute respiratory distress syndrome (ARDS) for transient improvement in oxygenation. Although multiple studies demonstrate improvements in oxygenation parameters, iNO has not consistently shown a mortality benefit or r...

Effects of inhaled nitric oxide during mechanical circulatory support: a prospective pilot study.

Variability in Oxygen Delivery Index during cardiopulmonary bypass is associated with acute kidney injury in neonates undergoing cardiac surgery

Background Oxygen delivery Index (DO2i) on cardiopulmonary bypass (CPB) is a well-established predictor of post-operative renal dysfunction after adult cardiac surgery. Limited data exists on DO2i in pediatric cardiac surgery. This study evaluates the association between DO2i and post-operative renal dysfunction in a...